Yukari Okubo (Y Okubo)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 67

Top Topics

Hidradenitis Suppurativa

Top Venues

The Journal of dermatology

Dermatology and therapy

American journal of clinical dermatology

Experimental dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy 14 (7) (2024)
Yukari Okubo, Satomi Kobayashi, Masamoto Murakami, Shigetoshi Sano, Natsuko Kikuta, Yoshiumi Ouchi, Tadashi Terui
Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial. American journal of clinical dermatology 25 (5) (2024)
Masanori Okuse, Masayuki Soekawa, Asako Itakura, Taisuke Kawamura, Sicily Mburu, Susan Frade, Yukari Okubo
Perspectives of Japanese patients on psoriatic disease burden: Results from "Psoriasis and Beyond," the Global Psoriatic Disease Survey. The Journal of dermatology (2024)
Shinichi Imafuku, Yukari Okubo, Yayoi Tada, Mamitaro Ohtsuki, Elizabeth Colston, Andrew Napoli, Yanqiu Shao, Subhashis Banerjee, Akimichi Morita
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial. The Journal of dermatology (2024)
Kenji Takami, Shigeyoshi Tsuji, Ryu Jokoji, Yukari Okubo, Mari Higashiyama
Paediatric pustulotic arthro-osteitis patient with an IL36RN variant, heterozygous c.115+6T>C, who was successfully treated with tonsillectomy: A case report and literature review. Experimental dermatology 33 (1) (2024)
Yoshihito Minami, Mirei Kanzaki, Chizu Egusa, Tomonobu Ito, Yukari Okubo, Yasuhiro Kawachi
A case of anaphylaxis after ingestion of Enokitake (Flammulina velutipes): Detection of the causative antigens. The Journal of dermatology (2024)
Miho Mori, Hiroshi Kawakami, Rie Tobita, Takashi Arai, Atsuko Satsuma, Ryoji Tsuboi, Yukari Okubo
Psoriasiform drug eruption: A case series with a review of the literature. Experimental dermatology 33 (9) (2024)
Akimichi Morita, Yukari Okubo, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, A E J Gibson, Frauke Becker, Nataliya Bogoeva, Mamitaro Ohtsuki
Expert consensus on systemic therapy for plaque psoriasis with limited skin involvement in JAPAN: Results from a DELPHI study. The Journal of dermatology (2024)
Shinichi Imafuku, Yukari Okubo, Yayoi Tada, Mamitaro Ohtsuki, Elizabeth Colston, Andrew Napoli, Yanqiu Shao, Subhashis Banerjee, Akimichi Morita
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial. The Journal of dermatology 51 (3) (2024)
Yukari Okubo, Satomi Kobayashi, Masamoto Murakami, Shigetoshi Sano, Natsuko Kikuta, Yoshiumi Ouchi, Tadashi Terui
Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial. American journal of clinical dermatology 25 (5) (2024)
Mamitaro Ohtsuki, Yukari Okubo, Hidehisa Saeki, Atsuyuki Igarashi, Shinichi Imafuku, Masatoshi Abe, Siddharth Chaudhari, Masafumi Yaguchi, Ayumi Emoto, Akimichi Morita
Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post-marketing surveillance study. The Journal of dermatology (2024)
Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy (2024)
Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy 14 (7) (2024)
Shinichi Imafuku, Yukari Okubo, Yayoi Tada, Mamitaro Ohtsuki, Elizabeth Colston, Andrew Napoli, Yanqiu Shao, Subhashis Banerjee, Akimichi Morita
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial. The Journal of dermatology 51 (3) (2024)
Shinichi Imafuku, Yukari Okubo, Yayoi Tada, Mamitaro Ohtsuki, Elizabeth Colston, Andrew Napoli, Yanqiu Shao, Subhashis Banerjee, Akimichi Morita
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial. The Journal of dermatology (2024)
Shinichi Imafuku, Yukari Okubo, Yayoi Tada, Mamitaro Ohtsuki, Elizabeth Colston, Andrew Napoli, Yanqiu Shao, Subhashis Banerjee, Akimichi Morita
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial. The Journal of dermatology (2024)
Mamitaro Ohtsuki, Yukari Okubo, Hidehisa Saeki, Atsuyuki Igarashi, Shinichi Imafuku, Masatoshi Abe, Siddharth Chaudhari, Masafumi Yaguchi, Ayumi Emoto, Akimichi Morita
Safety and effectiveness of apremilast in Japanese patients with psoriatic disease: Results of a post-marketing surveillance study. The Journal of dermatology 51 (7) (2024)
Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy 14 (7) (2024)
Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study. Dermatology and therapy 14 (7) (2024)
Yukari Okubo, Satomi Kobayashi, Masamoto Murakami, Shigetoshi Sano, Natsuko Kikuta, Yoshiumi Ouchi, Tadashi Terui
Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial. American journal of clinical dermatology (2024)
Yukari Okubo, Satomi Kobayashi, Masamoto Murakami, Shigetoshi Sano, Natsuko Kikuta, Yoshiumi Ouchi, Tadashi Terui
Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial. American journal of clinical dermatology 25 (5) (2024)
Kaoruko Yoshida, Takafumi Numata, Risa Sugisaki, Tomonobu Ito, Takayuki Nakai, Kozo Takagi, Kazutoshi Harada, Yukari Okubo
Orofacial granulomatosis associated with indium allergy and apical periodontitis. The Journal of dermatology (2024)
Kazuma Hayakawa, Tatsuo Maeda, Chizu Egusa, Yukari Okubo, Kazutoshi Harada
Topical application of imatinib mesylate ameliorated psoriasis-like skin lesions in imiquimod-induced murine model via angiogenesis inhibition. Experimental dermatology (2023)
Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G Langley, Delphine Deherder, Mizuho Matano, Veerle Vanvoorden, Maggie Wang, Mamitaro Ohtsuki, Hidemi Nakagawa
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Dermatology and therapy 13 (3) (2023)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Kenzo Takahashi, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis. The Journal of dermatology 50 (5) (2023)
Tadashi Terui, Yukari Okubo, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Natsuka Uehara, Takahiro Handa, Masayuki Tanaka, Wendy Zhang, Maria Paris, Masamoto Murakami
Author Correction: Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study. American journal of clinical dermatology (2023)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Kenzo Takahashi, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis. The Journal of dermatology 50 (5) (2023)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Kenzo Takahashi, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis. The Journal of dermatology 50 (5) (2023)
Yayoi Tada, Akimichi Morita, Keiichi Yamanaka, Michihiro Kono, Shinichi Imafuku, Yukari Okubo, Fumikazu Yamazaki, Taisuke Kawamura, Asako Itakura, Mamitaro Ohtsuki
Real-world retention rates and effectiveness of secukinumab in psoriasis: Results from a multicenter cohort study (RAILWAY). The Journal of dermatology (2023)
A David Burden, Yukari Okubo, M Zheng, Diamant Thaҫi, Peter Cornelis Maria van de Kerkhof, N Hu, M Quaresma, C Thoma, Siew Eng Choon
Efficacy of spesolimab for the treatment of generalized pustular psoriasis flares across pre-specified patient subgroups in the Effisayil 1 study. Experimental dermatology (2023)
Yayoi Tada, Mayumi Komine, Yukari Okubo, Katsuyoshi Habiro, Katsuki Tsuritani, Akimichi Morita
Treatment patterns of systemic drug use in Japanese patients with plaque psoriasis: A retrospective chart review. The Journal of dermatology (2023)
Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G Langley, Delphine Deherder, Mizuho Matano, Veerle Vanvoorden, Maggie Wang, Mamitaro Ohtsuki, Hidemi Nakagawa
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Dermatology and therapy 13 (3) (2023)
Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G Langley, Delphine Deherder, Mizuho Matano, Veerle Vanvoorden, Maggie Wang, Mamitaro Ohtsuki, Hidemi Nakagawa
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Dermatology and therapy (2023)
Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G Langley, Delphine Deherder, Mizuho Matano, Veerle Vanvoorden, Maggie Wang, Mamitaro Ohtsuki, Hidemi Nakagawa
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Dermatology and therapy 13 (3) (2023)
Akihiko Asahina, Yukari Okubo, Akimichi Morita, Yayoi Tada, Atsuyuki Igarashi, Richard G Langley, Delphine Deherder, Mizuho Matano, Veerle Vanvoorden, Maggie Wang, Mamitaro Ohtsuki, Hidemi Nakagawa
Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study. Dermatology and therapy (2023)
Tadashi Terui, Yukari Okubo, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Natsuka Uehara, Takahiro Handa, Masayuki Tanaka, Wendy Zhang, Maria Paris, Masamoto Murakami
Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study. American journal of clinical dermatology (2023)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Shigetoshi Sano, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). The Journal of dermatology 50 (2) (2022)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Shigetoshi Sano, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). The Journal of dermatology 50 (2) (2022)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Shigetoshi Sano, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). The Journal of dermatology 50 (2) (2022)
Hidehisa Saeki, Tomotaka Mabuchi, Akihiko Asahina, Masatoshi Abe, Atsuyuki Igarashi, Shinichi Imafuku, Yukari Okubo, Mayumi Komine, Shigetoshi Sano, Hideshi Torii, Akimichi Morita, Hiroshi Yotsuyanagi, Akira Watanabe, Mamitaro Ohtsuki, null null
English version of Japanese guidance for use of biologics for psoriasis (the 2022 version). The Journal of dermatology (2022)
Keiichi Yamanaka, Yukari Okubo, Ikuko Yasuda, Nobuo Saito, Izabella Messina, Akimichi Morita
Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study. The Journal of dermatology 50 (2) (2022)
Akimichi Morita, Tsen Fang Tsai, Evelyn Yap Wen Yee, Yukari Okubo, Shinichi Imafuku, Min Zheng, Ling Li, Manuel Quaresma, Christian Thoma, Siew Eng Choon
Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled Effisayil™ 1 study. The Journal of dermatology (2022)
Keiichi Yamanaka, Yukari Okubo, Ikuko Yasuda, Nobuo Saito, Izabella Messina, Akimichi Morita
Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study. The Journal of dermatology 50 (2) (2022)
Keiichi Yamanaka, Yukari Okubo, Ikuko Yasuda, Nobuo Saito, Izabella Messina, Akimichi Morita
Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study. The Journal of dermatology (2022)
Keiichi Yamanaka, Yukari Okubo, Ikuko Yasuda, Nobuo Saito, Izabella Messina, Akimichi Morita
Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study. The Journal of dermatology 50 (2) (2022)
Keiichi Yamanaka, Yukari Okubo, Ikuko Yasuda, Nobuo Saito, Izabella Messina, Akimichi Morita
Efficacy and safety of risankizumab in Japanese patients with generalized pustular psoriasis or erythrodermic psoriasis: Primary analysis and 180-week follow-up results from the phase 3, multicenter IMMspire study. The Journal of dermatology 50 (2) (2022)
H Seshimo, Tomonobu Ito, C Egusa, T Numata, T Kobayashi, N Abe, T Niitsuma, Yukari Okubo, K Harada
Response to 'Reply to "A case of anaphylactic shock induced by mealworm antigen in the bite of a Japanese flying squirrel" by Seshimo et al.' by Schmid-Grendelmeier and Guillet. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (9) (2021)
Yukari Okubo, Hitomi Morishima, Richuan Zheng, Tadashi Terui
Sustained efficacy and safety of guselkumab in patients with palmoplantar pustulosis through 1.5 years in a randomized phase 3 study. The Journal of dermatology 48 (12) (2021)
Yukari Okubo, Hitoe Torisu-Itakura, Takao Hanada, Toshihiko Aranishi, Sachie Inoue, Mamitaro Ohtsuki
Evaluation of treatment satisfaction misalignment between Japanese psoriasis patients and their physicians - Japanese psoriasis patients and their physicians do not share the same treatment satisfaction levels. Current medical research and opinion 37 (7) (2021)
Yoshiki Takeda, Hiroshi Kawakami, Miho Mori, Jun-Ichiro Hiruma, Kazuki Fujimori, Rika Umefune, Kenichirou Mae, Masuyoshi Saitou, Kazutoshi Harada, Yukari Okubo
Case of generalized pustular psoriasis preceded by acute generalized pustular bacterid-like eruptions on the palms and soles. The Journal of dermatology 48 (6) (2021)
H Seshimo, Tomonobu Ito, C Egusa, Takafumi Numata, T Kobayashi, N Abe, T Niitsuma, Yukari Okubo, Kazutoshi Harada
A case of anaphylactic shock induced by mealworm antigen in the bite of a Japanese flying squirrel. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (8) (2021)
Atsuyuki Igarashi, Hidemi Nakagawa, Akimichi Morita, Yukari Okubo, Shigetoshi Sano, Shinichi Imafuku, Yayoi Tada, Masaru Honma, Alan M Mendelsohn, Masaki Kawamura, Mamitaro Ohtsuki
Efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 64-week phase 3 study (reSURFACE 1). The Journal of dermatology 48 (6) (2021)
Yukari Okubo, Nirali Kotowsky, Ran Gao, Kumiko Saito, Akimichi Morita
Clinical characteristics and health-care resource utilization in patients with generalized pustular psoriasis using real-world evidence from the Japanese Medical Data Center database. The Journal of dermatology 48 (11) (2021)
Akimichi Morita, Nirali Kotowsky, Ran Gao, Reiko Shimizu, Yukari Okubo
Patient characteristics and burden of disease in Japanese patients with generalized pustular psoriasis: Results from the Medical Data Vision claims database. The Journal of dermatology 48 (10) (2021)
Bruce E Strober, Joyce Leman, Maja Mockenhaupt, Juliana Nakano de Melo, Ahmed Nassar, Vimal H Prajapati, Paolo Romanelli, Julien Seneschal, Athanasios Tsianakas, Lee Yoong Wei, Masahito Yasuda, Ning Yu, Ana C Hernandez Daly, Yukari Okubo
Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line. Dermatology and therapy 12 (2) (2021)
Yukari Okubo, Mamitaro Ohtsuki, Mayumi Komine, Shinichi Imafuku, Nastya Kassir, Rosemary Petric, Osamu Nemoto
Population pharmacokinetic and exposure-response analysis of apremilast in Japanese subjects with moderate to severe psoriasis. The Journal of dermatology 48 (11) (2021)
Miho Mori, Rie Tobita, Chizu Egusa, Tatsuo Maeda, Namiko Abe, Hiroshi Kawakami, Kenichirou Mae, Yuka Matsumoto, Yasuhiro Kawachi, Yukari Okubo
Clinical background of patients with psoriasiform skin lesions due to tumor necrosis factor antagonist administration at a single center. The Journal of dermatology 48 (11) (2021)
Naotaka Serizawa, Shizuka Okazaki, Yohei Otsuka, Mototaka Koto, Kyochika Okabe, Michiko Ito, Takashi Morita, Toshihiko Hoashi, Hidehisa Saeki, Namiko Abe, Miho Mori, Yukari Okubo, Yumiko Yano, Hiroshi Mitsui, Naoko Kanda
Dietary habits in Japanese patients with palmoplantar pustulosis. The Journal of dermatology 48 (3) (2021)
Shinichi Imafuku, Hidemi Nakagawa, Atsuyuki Igarashi, Akimichi Morita, Yukari Okubo, Shigetoshi Sano, Yayoi Tada, Osamu Nemoto, Stephen J Rozzo, Masaki Kawamura, Mamitaro Ohtsuki
Long-term efficacy and safety of tildrakizumab in Japanese patients with moderate to severe plaque psoriasis: Results from a 5-year extension of a phase 3 study (reSURFACE 1). The Journal of dermatology 48 (6) (2021)
Toshiyuki Yamamoto, Tomoko Hiraiwa, Rie Tobita, Hirofumi Hirano, Kana Masuda-Kuroki, Madoka Ishii, Masamoto Murakami, Tadashi Terui, Yukari Okubo
Characteristics of Japanese patients with pustulotic arthro-osteitis associated with palmoplantar pustulosis: a multicenter study. International journal of dermatology 59 (4) (2020)
Shinichi Imafuku, Osamu Nemoto, Yukari Okubo, Mayumi Komine, Peter Schafer, Rosemary Petric, Mamitaro Ohtsuki
Pharmacodynamic analysis of apremilast in Japanese patients with moderate to severe psoriasis: Results from a phase 2b randomized trial. The Journal of dermatology 48 (1) (2020)
Yuka Matsumoto, N Abe, R Tobita, H Kawakami, H Nakayama, Y Setoguchi, R Tsuboi, Yukari Okubo
The risk of interstitial lung disease during biological treatment in Japanese patients with psoriasis. Clinical and experimental dermatology 45 (7) (2020)
Akimichi Morita, Hidetoshi Takahashi, Kentaro Ozawa, Shinichi Imafuku, Nakama Takekuni, Kenzo Takahashi, Takashi Matsuyama, Yukari Okubo, Yiwei Zhao, Susumu Kitamura, Keiko Takei, Masayuki Yokoyama, Nobukazu Hayashi, Tadashi Terui
Long-term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open-label phase 3 results. The Journal of dermatology 48 (1) (2020)
Kana Masuda-Kuroki, Masamoto Murakami, Mari Kishibe, Satomi Kobayashi, Yukari Okubo, Toshiyuki Yamamoto, Tadashi Terui, Koji Sayama
Diagnostic histopathological features distinguishing palmoplantar pustulosis from pompholyx. The Journal of dermatology 46 (5) (2019)
Akimichi Morita, Hidetoshi Takahashi, Kentaro Ozawa, Shinichi Imafuku, Takekuni Nakama, Kenzo Takahashi, Takashi Matsuyama, Yukari Okubo, Susumu Kitamura, Naoto Matsuda, Yiwei Zhao, Masayuki Yokoyama, Nobukazu Hayashi, Tadashi Terui
Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa. The Journal of dermatology 46 (9) (2019)
Yukari Okubo, Mamitaro Ohtsuki, Akimichi Morita, Masako Yamaguchi, Tomohiro Shima, Yumiko Tani, Hidemi Nakagawa, null null
Long-term efficacy and safety of secukinumab in Japanese patients with moderate to severe plaque psoriasis: 3-year results of a double-blind extension study. The Journal of dermatology 46 (3) (2019)
Hiroshi Kawakami, Yume Nagaoka, Hirofumi Hirano, Yuka Matsumoto, Namiko Abe, Ryoji Tsuboi, Yoshihiko Kanno, Yukari Okubo
Evaluation of the efficacy of granulocyte and monocyte adsorption apheresis on skin manifestation and joint symptoms of patients with pustulotic arthro-osteitis. The Journal of dermatology 46 (2) (2018)